Thank you for your interest in becoming a Clarity Study Investigator

Our Study Investigators play a pivotal role in Clarity’s efforts to advance innovation in science, assist healthcare professionals in providing a higher standard of care and, ultimately, improve the quality of life for patients worldwide.

To learn more, please call today to speak to a study representative or submit the form below.

OPTIMA-G

PAIN STUDY*

(Observing Pain Transdermal Treatments-Improving and Managing All GI Symptoms)
The OPTIMA-G study is aimed at evaluating patients’ experiences and/or perceptions for those who have been prescribed a topical/transdermal pain medication. Changes in pain and other symptoms will be evaluated.
VISIT STUDY PAGE

TAPER-P

PAIN STUDY*

(Treating Athletes in Pain: Evaluating Return to Play)
The TAPER-P study evaluates perceptions and patient responses among non-elite and elite athletes who have been prescribed a topical analgesic and, if applicable, scar medication for an associated scar.
VISIT STUDY PAGE

TARGET

SCAR & BURN STUDY*

(Topical Silicone in Restoring Scars and Burn Tissue: Evaluating Therapy)
The TARGET study evaluates patients’ experiences and/or perceptions of prescribed topical scar medication to treat new scars, old scars, surgical scars, burn scars, keloids, and stretch marks.
VISIT STUDY PAGE

TRIPLE-A

ALLERGY STUDY*

(Assisting and Accommodating Allergy Patients)
The TRIPLE-A study evaluates patients’ experiences and/or perceptions of premedications and preventative medications prescribed while undergoing Allergy Immunotherapy (Subcutaneous (SCIT) or Transdermal (TdIT)).
VISIT STUDY PAGE

TREAT

ALLERGY STUDY*

(Transdermal Relief: Evaluating Allergy Topicals)
The TREAT Study will evaluate patients’ experiences and or perceptions of prescribed transdermal immunotherapy (TdIT) to treat seasonal and perennial allergy symptoms.

VISIT STUDY PAGE
*All participants must meet full inclusion criteria to participate in Clarity’s studies. All medications observed in Clarity’s studies are prescribed by the Provider/Study Investigator based on medical necessity. For more information, please refer to the Study Protocols and agreements.

Become an Investigator

To Apply to Become A Study Investigator or to Join Our Network, Please Provide the Following Information:
  • Investigator Information

  • Form Verification

Areas of Research

We are currently conducting and developing clinical studies throughout the US in the following key areas:

Allergy
Chronic Sinusitis
Depression/Mental Health
Dermatology
Diabetes
GI
Immunotherapy
Mental Health
Oncology
Pain Management
Pharmacogenetics
Rheumatoid Arthritis
Scar & Burn
Sleep
Toxicology
Women’s Health
Xerostomia (Dry Mouth)

Worldwide Recognition

Our studies continue to be recognized at leading national and international meetings. We have presented data at various conferences; winning first place for “Best Scientific Presentation/Data” at the American Professional Wound Care Association.

Peer reviewed articles related to our study data have been published and more are in final stages of submission.

BROWSE CONFERENCES & PUBLICATIONS

Current Studies

Scar & Burn

TARGET Study

(_Topic_Al Silicone in _Restorin_G Scars and Burn Tissue - _Evaluating _Therapy)

TARGET is a current, large-scale IRB-approved observational study on the effectiveness of topical/transdermal treatments for scar/burn characteristics, symptoms, and patient perceptions. It further evaluates the reduction of pain during the course of treatment.

Key Interim Results

69% of patients noticed reduction in scar size, results confirmed by clinician measurements, which showed a statistically significant reduction in the percentage of patients with largest (>20cm) scars from baseline (p<.003)

Over an average 128 days of scar/burn cream treatment use, patients reduced their usage of pain medications by 69% (p<.001)

Patients also reported reductions in itching (p<.001) and scar/burn interference with general activity, mood, sleep, life enjoyment, and an improvement in emotional well-being with the use of the treatment compound (p<.05)

Patients reported no serious adverse events and that the creams were safe and well-tolerated.

Allergy

TREAT Study

(_Transdermal _Relief: _Evaluating _Allergy _Topicals for Perennial Allergic Rhinitis)

TREAT is an IRB-approved observational study to evaluate patients’ experiences and/or perceptions of prescribed transdermal allergy medications to treat seasonal and perennial allergy symptoms.

Pain

OPTIMA-G Study

(_Observing _Pain _Transdermal Treatments—_Improving and _Managing _All _GI Symptoms)

Clarity Science is conducting an IRB-approved observational study aimed at evaluating patients’ experiences and/or perceptions for those who have been prescribed a topical/transdermal pain medication. Pain and other symptoms will be evaluated by patient answers to validated assessment scales.

Acute & Chronic Pain

TAPER-P Study

(_Treating _Athletes in _Pain: _Evaluating _Return to _Play)

Clarity Science is conducting an IRB- approved observational study aimed at evaluating efficacy and perceptions among non-elite and elite athletes with acute and chronic pain who have been treated with a topical analgesic.

Allergy

Study

(_Assisting and _Accommodating _Allergy Patients)

The TRIPLE-A study evaluates patients’ experiences and/or perceptions of premedications and preventative medications prescribed while undergoing Allergy Immunotherapy (Subcutaneous (SCIT) or Transdermal (TdIT)).

If you are a physician or healthcare provider interested in becoming a Study Investigator for any of our current or future studies, we would like to hear from you. Please complete our online Study Investigator Application or call our dedicated Healthcare Provider HelpDesk at
1-800-616-9403.